Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
41,06339,12849,46353,94470,320
Cost of revenue
Cost of revenue
-15,759-15,554-18,252-21,085-23,241
Gross Profit
Gross Profit
25,303
23,574
31,210
32,859
47,079
Sales, general & ad...
Sales, general and administrative
-10,843-10,957-12,492-14,637-17,854
Depreciation
Depreciation and amortization
-1,233-1,425-1,689-1,862-2,556
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
13,227
11,192
17,029
16,359
26,669
 
      
Interest expense
Interest expense
-23-13-35-61-9
Other income/exp...
Other income(expense)
7491,1341,5561,8960
Profit before tax
Profit before tax
13,953
12,313
18,551
18,195
26,660
Income tax & other ta...
Income tax and other taxes
3,3543,5435,0234,4296,818
Net income from c...
Net income from continuing operations
10,6008,77013,52713,76519,843
Extraordinary & disc...
Extraordinary items & Discontinued Ops
40000
Share of associates
Share of associates
00000
Minority Interest
Minority Interest
00000
Net Income
Net income
10,604
8,770
13,527
13,765
19,843
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
10,6048,77013,52713,76519,843
Basic shares
Basic shares
265265265265266
Diluted Shares
Diluted Shares
265265265265266
EPS Basic
EPS Basic in Rupees
39.9533.0450.9651.8574.73
EPS Diluted
EPS Diluted in Rupees
39.95
33.04
50.96
51.85
74.73